Altasciences
Laval, CA · 3 known investors
Find your way into Altasciences
Altasciences operates a drug development platform that integrates nonclinical research, bioanalysis, manufacturing, and Phase I/II clinical execution to compress early-stage drug development timelines from industry standards of 27–51 months to as little as 18 months. The company serves biotech sponsors developing small molecules, monoclonal antibodies, and emerging modalities through parallel workstreams across all development phases.
Founders & leadership
MR
Marie-Hélène RaigneauinChief Executive Officer
CK
Catherine KonidasinChief Administrative Officer
DB
Dr. Beatrice SetnikChief Scientific Officer
DG
Dr. Gaetano MorelliExecutive Vice President Medical Affairs, Chief Medical Officer
SM
Steve MasoninCo-Chief Operating Officer
RS
Robert SabelliinCo-Chief Operating Officer
DG
David GrégoireinChief Quality and Compliance Officer
JC
Julie-Ann CabanainChief Marketing Officer
MR
Mariano RodriguezinExecutive Vice President and Chief Financial Officer
Investors · 3
Frequently asked questions
- What does Altasciences do?
- Altasciences operates a drug development platform that integrates nonclinical research, bioanalysis, manufacturing, and Phase I/II clinical execution to compress early-stage drug development timelines from industry standards of 27–51 months to as little as 18 months. The company serves biotech sponsors developing small molecules, monoclonal antibodies, and emerging modalities through parallel workstreams across all development phases.
- Who are Altasciences's investors?
- Altasciences's investors include Novo Holdings, Kilmer Group, Signet Healthcare Partners.
- Where is Altasciences headquartered?
- Altasciences is headquartered in Laval, CA.